Chemistry:Fexuprazan
From HandWiki
Short description: Chemical compound
 | |
| Clinical data | |
|---|---|
| Trade names | Fexuclue |
| Other names | Abeprazan; DWP14012; DWP-14012 |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C19H17F3N2O3S |
| Molar mass | 410.41 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Fexuprazan (trade name Fexuclue) is a drug for the treatment of gastroesophageal reflux disease (GERD).[1] It is a potassium-competitive acid blocker.[2]
Fexuprazan is approved for use in South Korea and Mexico.[3][4]
References
- ↑ Ramani, Azaan; Merchant, Alisha; Cash, Brooks D. (2023). "Review of the clinical development of fexuprazan for gastroesophageal reflux–related disease". European Journal of Clinical Pharmacology 79 (8): 1023–1029. doi:10.1007/s00228-023-03521-4. PMID 37344679.
- ↑ Kim, Gwang Ha; Choi, Myung-Gyu; Kim, Jin Il; Lee, Soo Teik; Chun, Hoon Jai; Lee, Kook Lae; Choi, Suk Chei; Jang, Jae-Young et al. (2023). "Efficacy and Safety of Fexuprazan in Patients with Acute or Chronic Gastritis". Gut and Liver 17 (6): 884–893. doi:10.5009/gnl220457. PMID 36789577.
- ↑ "펙수클루정40밀리그램(펙수프라잔염산염)". https://nedrug.mfds.go.kr/pbp/CCBBB01/getItemDetail?itemSeq=202108192.
- ↑ "Daewoong Pharma's GER drug gets product OK from Mexico". Korea Economic Daily. October 19, 2023. https://www.kedglobal.com/bio-pharma/newsView/ked202310190002.
 |  |
